ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,931Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 99

$2.04M Total Retail Price of All Prescriptions

Rank: 1 out of 99

1,246 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 1,246 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

5% of this provider’s 17,315 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 46%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $120 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 2,563 1,712 1 1
PRAVASTATIN SODIUM 1,348 910 2 18
METFORMIN HCL 1,011 632 3 3
GLIMEPIRIDE 856 623 4 7
LISINOPRIL 782 511 5 11
SIMVASTATIN 603 429 6 8
JANUVIA 586 437 7 15
GLIPIZIDE 584 452 8 25
INSULIN SYRINGE 553 295 9 6
AMLODIPINE BESYLATE 500 365 10 13
GLYBURIDE 469 323 R 11 54
GABAPENTIN 459 302 12 22
ATORVASTATIN CALCIUM 413 295 13 16
FUROSEMIDE 402 278 14 24
GEMFIBROZIL 401 271 10 15 67
LANTUS 382 204 16 4
METOPROLOL TARTRATE 370 271 17 39
SYNTHROID 345 267 18 2
GLYBURIDE-METFORMIN HCL 314 254 R 19 65
PEN NEEDLE 287 153 20 5
NOVOLOG 268 117 21 10
NOVOLIN 70-30 266 176 22 29
LOSARTAN POTASSIUM 254 242 23 21
LANTUS SOLOSTAR 247 125 24 9
AMITRIPTYLINE HCL 241 160 R 25 80
ATENOLOL 233 176 26 40
CARVEDILOL 223 145 27 28
OMEPRAZOLE 219 149 28 41
FENOFIBRATE 213 157 29 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 208 137 30 38
NOVOLOG FLEXPEN 206 85 31 14
HUMALOG 195 99 32 12
METFORMIN HCL ER 194 121 33 17
ALENDRONATE SODIUM 192 166 34 35
ONGLYZA 185 108 35 58
ZETIA 185 125 35 47
POTASSIUM CHLORIDE 178 125 37 52
DIOVAN 176 132 38 44
CLONIDINE HCL 172 113 39 59
CRESTOR 168 83 40 20
ZOLPIDEM TARTRATE 162 77 41 45
METHIMAZOLE 158 130 42 19
LIOTHYRONINE SODIUM 155 114 43 55
HUMULIN 70-30 147 105 44 64
HYDRALAZINE HCL 138 102 45 100
DIOVAN HCT 135 121 46 76
CLOPIDOGREL 133 93 47 94
MELOXICAM 133 96 47 89
NOVOLOG MIX 70-30 128 79 49 43
METOPROLOL SUCCINATE 127 87 50 37
HYDROCHLOROTHIAZIDE 125 80 51 23
HUMULIN N 121 79 52 42
NOVOLIN N 119 43 53 61
NEXIUM 113 94 54 60
PANTOPRAZOLE SODIUM 107 50 55 97
SPIRONOLACTONE 104 54 56 69
ALLOPURINOL 102 80 57 72
CITALOPRAM HBR 100 70 58 67
LOSARTAN-HYDROCHLOROTHIAZIDE 99 76 59 46
KLOR-CON M20 95 67 60 78
TRAMADOL HCL 94 69 61 82
NOVOLOG MIX 70-30 FLEXPEN 93 65 62 31
LOVAZA 89 33 63 86
HYDROCORTISONE 85 53 64 48
RANITIDINE HCL 83 40 65 114
PAROXETINE HCL 83 59 65 111
BENICAR HCT 81 72 67 105
LANSOPRAZOLE 80 52 68 115
TRICOR 80 52 68 92
PLAVIX 79 65 70 104
ARMOUR THYROID 78 57 R 71 136
PREDNISONE 78 71 71 70
BYETTA 77 19 73 50
NIASPAN 76 60 74 62
VYTORIN 74 59 75 99
TRAZODONE HCL 72 46 76 108
LIPITOR 72 45 76 66
ACTOS 71 56 78 27
TRILIPIX 69 42 79 96
HUMALOG MIX 75-25 69 48 79 34
ANDROGEL 67 39 S3 81 88
LEVEMIR FLEXPEN 65 31 82 26
HUMULIN R 65 30 82 49
ESCITALOPRAM OXALATE 63 22 84 112
LEVOXYL 62 35 85 30
CYMBALTA 61 48 86 90
LOVASTATIN 60 48 87 53
TRIAMTERENE-HCTZ 59 56 88 87
TAMSULOSIN HCL 57 49 89 108
CEPHALEXIN 55 34 90 120
VERAPAMIL ER 55 46 90 121
OXYBUTYNIN CHLORIDE 51 37 92 166
PREMARIN 50 49 R 93 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.